Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis
about
Moving targets: Emerging roles for MMPs in cancer progression and metastasisTumor associated macrophage: a review on the phenotypes, traits and functionsHypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to HypoxiaActive stromelysin-3 (MMP-11) increases MCF-7 survival in three-dimensional Matrigel culture via activation of p42/p44 MAP-kinaseUnconventional activation mechanisms of MMP-26, a human matrix metalloproteinase with a unique PHCGXXD cysteine-switch motifThe role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatinAndrogen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitorsMatrix metalloproteinase-7 and premalignant host responses in Helicobacter pylori-infected miceStudy of matrix metalloproteinases and their inhibitors in prostate cancer.Cancer and the tumor microenvironment: a review of an essential relationship.Matrix metalloproteases in head and neck cancer.Matrix metalloproteinase 8 deficiency in mice exacerbates inflammatory arthritis through delayed neutrophil apoptosis and reduced caspase 11 expression.Helicobacter pylori and gastric cancer: factors that modulate disease risk.Matrix metalloproteinases in tumorigenesis: an evolving paradigm.Matrix metalloproteinase-21 is expressed epithelially during development and in cancer and is up-regulated by transforming growth factor-beta1 in keratinocytes.Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis.Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas.Discovery of chemokine substrates for matrix metalloproteinases by exosite scanning: a new tool for degradomics.Proteolytic action of kallikrein-related peptidase 7 produces unique active matrix metalloproteinase-9 lacking the C-terminal hemopexin domainsProteases, extracellular matrix, and cancer: a workshop of the path B study sectionMTGR1 is required for tumorigenesis in the murine AOM/DSS colitis-associated carcinoma modelTumour macrophages as potential targets of bisphosphonates.A phenotype from tumor stroma based on the expression of metalloproteases and their inhibitors, associated with prognosis in breast cancer.Kaposi's sarcoma-associated herpesvirus infection promotes invasion of primary human umbilical vein endothelial cells by inducing matrix metalloproteinases.Matrix Metalloproteinases and Bladder Cancer: What is New?Study of matrix metalloproteinases and their inhibitors in breast cancer.Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse.Genetic polymorphisms in the MMP-7 gene and breast cancer survivalMatrilysin-1 mediates bronchiolization of alveoli, a potential premalignant change in lung cancer.Common MMP-7 polymorphisms and breast cancer susceptibility: a multistage study of association and functionality.Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis.Androgen receptors expressed by prostatic stromal cells obtained from younger versus older males exhibit opposite roles in prostate cancer progression.A loss of host-derived MMP-7 promotes myeloma growth and osteolytic bone disease in vivo.MMP7 and MMP8 genetic polymorphisms in bladder cancer patients.Analysis of the intricate relationship between chronic inflammation and cancer.Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer.Methanolic extract of white asparagus shoots activates TRAIL apoptotic death pathway in human cancer cells and inhibits colon carcinogenesis in a preclinical model.Thymocyte development in the absence of matrix metalloproteinase-9/gelatinase B.Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface.Novel bis-(arylsulfonamide) hydroxamate-based selective MMP inhibitors
P2860
Q27008735-E39DDEE9-8FD4-450C-ABB6-47E912DE31C1Q27010428-9211F436-8480-4A6D-A69E-91F37655BE66Q28085029-F8557D8D-6E7C-4613-9F9B-15A0A5769B03Q28185337-BB04B0ED-E395-4BA6-9D33-7A77F0704CDAQ28206320-CD24D2B1-B845-4A0E-BFC7-D89622FC0F87Q28474925-8F1489E7-4843-4FC5-965E-CE262885BBE1Q33338236-D37E58A1-6757-40CF-BB3A-38A0CAF7296FQ33584273-B76EF185-8DC6-44DF-8F24-C6F3C08041ADQ33708162-B9B890FD-63B8-48C4-8F2F-D981EB623A33Q33806357-8376DEBA-673E-431A-890C-C58C78723FDCQ33863220-67B3C858-EF87-4A5B-8C23-157666C18AC7Q34152675-F89CA9E6-9888-4C90-BEEC-39C87CDD0760Q34189885-12A93BF1-79F3-486B-84BE-549DD20EA408Q34199345-41851E22-06EC-47FE-A68C-97BEE42678D7Q34285779-DD910F2E-F6E6-4660-BB45-8D7A1E480704Q34611577-4D13A73D-B4F6-46CD-9871-0D1B3E2EBC55Q34792019-9F00B9F3-274B-4E93-9A22-27C5CE0B0075Q35000708-525A2063-55FD-4EED-906B-F8A4F924F08BQ35068692-8F1D883B-E861-4AC0-995E-F4A4394E7394Q35097428-960B25DC-D88E-4F87-A674-FCEA29F2613DQ35147203-E89D8DFE-5875-4D27-89E6-D9A2A1A4DD52Q35547309-6B1708AC-871A-410B-859C-40625C0C89D0Q35798885-934085F5-BAD5-4827-870F-D45AB47E06D5Q35914351-94D21D4D-55DB-4813-9F13-2D34F7828501Q36125093-589C362E-2011-474A-8213-C012BD2C2703Q36610142-A979F890-E826-4D8C-AECB-8275D88C5DA4Q36611308-5C43A68D-C0BD-4EC9-A1C3-6D8CCCB47457Q37003874-C33F2B25-DBAB-4D14-8140-4736277E2FF5Q37278448-9624FF86-C772-471D-9208-08D1DAB07A88Q37282674-6C2D95EF-6A34-4BF2-8646-DA6ADBF473FFQ37350475-ED0D336D-866C-4473-BF2F-5B73C9BF22A5Q37436975-3C60CE25-29C7-4455-A6D4-7CBC49A90C5AQ37671439-4BD89F2E-E781-400B-9E81-096CCCD9A8F5Q37711553-4F13CCF1-E86E-4E0E-94B7-1B16E0382227Q38458724-998D8C18-5A7D-4776-8708-F02FDAA8ACEEQ38848404-D7527256-6641-4D29-BF40-4F96379AEA31Q39141466-B20B8C72-1674-44B1-AFDF-F32C3623018CQ39586822-B2C6815C-15C7-4145-8C69-7AD3ABE3B7A1Q40568311-6889A866-1465-4813-A583-47E909F9A3A3Q41175771-3C06ECFC-095B-4B62-9A66-48880225E63A
P2860
Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis
description
2001 nî lūn-bûn
@nan
2001 թուականին հրատարակուած գիտական յօդուած
@hyw
2001 թվականին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis
@ast
Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis
@en
Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis
@nl
type
label
Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis
@ast
Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis
@en
Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis
@nl
prefLabel
Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis
@ast
Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis
@en
Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis
@nl
P2093
P2860
P3181
P356
P1433
P1476
Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis
@en
P2093
H C Crawford
L M Matrisian
T Vargo-Gogola
P2860
P304
P3181
P356
10.1038/SJ.NEO.7900190
P407
P577
2001-01-01T00:00:00Z